For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Sumitomo Dainippon Pharma Oncology, Inc.

USPTO Granted Patents = 11

EPO Patents = 3

Forward Citations = 22

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Adam Siddiqui-Jain (5 out of 25 patents)

Steven L Warner (3 out of 36 patents)

Paul Flynn (3 out of 7 patents)

4. David J Bearss (3 out of 50 patents)

5. Hitoshi Ban (2 out of 37 patents)

6. Chiang Jia Li (2 out of 57 patents)

7. Jason Marc Foulks (2 out of 7 patents)

8. Wei Li (2 out of 16 patents)

9. Clifford J Whatcott (2 out of 9 patents)

10. Yuji Fujiwara (2 out of 3 patents)

11. Yuka Arikawa (2 out of 4 patents)

12. Yong Xu (2 out of 34 patents)

13. Xiaohui Liu (2 out of 11 patents)

14. Michael David Saunders (2 out of 9 patents)

15. Koc-Kan Ho (2 out of 50 patents)

11 patents: Sort by Forward Citations

1. 11299469 - Naphthofuran derivatives, preparation, and methods of use thereof (2022-04-12),

2. 11279694 - Alvocidib prodrugs and their use as protein kinase inhibitors (2022-03-22),

3. 11040038 - Methods for treating diseases associated with abnormal ACVR1 expression and ACVR1 inhibitors for use in the same (2021-06-22),

4. 11034710 - CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer (2021-06-15),

5. 11013741 - AXL kinase inhibitors and use of the same (2021-05-25),

6. 10934309 - Tricyclic quinone derivative (2021-03-02),

7. 10875864 - Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors (2020-12-29),

8. 10851075 - Stat3 pathway inhibitors and cancer stem cell inhibitors (2020-12-01),

9. 10835537 - Combination therapies for treatment of cancer (2020-11-17),

10. 10766865 - PKM2 modulators and methods for their use (2020-09-08),

11. 10752594 - JAK1 and ALK2 inhibitors and methods for their use (2020-08-25),

Sumitomo Dainippon Pharma Oncology, Inc. is a leading biopharmaceutical company specializing in oncology research and development. We are dedicated to discovering and delivering innovative treatments that improve the lives of cancer patients worldwide. Our comprehensive portfolio includes targeted therapies, immunotherapies, and supportive care products. Through strategic partnerships and collaborations, we strive to advance the field of oncology and make a lasting impact on patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

11 Patents

#190 in Cambridge, MA

#1,616 in Massachusetts

#26,752 in US

#50,255 in the World

Cambridge, MA, United States of America

Sumitomo Dainippon Pharma Oncology, Inc.

Forward Citations = 22

43 inventors:

Adam Siddiqui-Jain (5 out of 25 patents)

Steven L Warner (3 out of 36 patents)

Paul Flynn (3 out of 7 patents)

4. David J Bearss (3 out of 50 patents)

5. Hitoshi Ban (2 out of 37 patents)

Please report any incorrect information to support@idiyas.com

Loading…